Results 21 to 30 of about 95,906 (268)

Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.

open access: yesPLoS ONE, 2011
BackgroundBetacellulin (BTC), a member of the epidermal growth factor family, is known to play an important role in regulating growth and differentiation of pancreatic beta cells.
Yoon Sin Oh   +4 more
doaj   +1 more source

ErbB polymorphisms: Insights and implications for response to targeted cancer therapeutics

open access: yesFrontiers in Genetics, 2015
Advances in high-throughput genomic-scanning have expanded the repertory of genetic variations in DNA sequences encoding ErbB tyrosine kinase receptors in humans, including single nucleotide polymorphisms (SNPs), polymorphic repetitive elements ...
Moulay A Alaoui-Jamali   +2 more
doaj   +1 more source

Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer

open access: yesBreast Cancer: Targets and Therapy, 2021
Mohamad Adham Salkeni,1 Wajeeha Rizvi,2 Kyaw Hein,3 Gerald M Higa4 1Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; 2Department of Internal Medicine, West Virginia University ...
Salkeni MA, Rizvi W, Hein K, Higa GM
doaj  

Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma

open access: yesMolecular Oncology, 2023
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest of cancers. Attempts to develop targeted therapies still need to be established. Some oncogenic mechanisms in PDAC carcinogenesis harness the EGFR/ERBB receptor family. To explore the effects
Kathrin Hedegger   +7 more
doaj   +1 more source

Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer

open access: yesFrontiers in Oncology, 2019
Despite the gradual decrease in incidence, gastric cancer is still the third leading cause of cancer death worldwide. Although chemotherapy enhances overall survival and quality of life in advanced disease, the median overall survival is < 12 months ...
Chiara Arienti   +2 more
doaj   +1 more source

Ultrasound microbubble-mediated CRISPR/Cas9 knockout of in HEC-1A cells

open access: yesJournal of International Medical Research, 2019
Objective Epidermal growth factor receptor 2 (C-erbB-2) is one of the most frequently mutated oncogenes in human tumors. We aimed to evaluate the knockout efficiency of clustered regularly interspaced short palindromic repeat (CRISPR) technology using ...
Junhong Cai   +3 more
doaj   +1 more source

The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas

open access: yesDiagnostic Pathology, 2010
Background Endometrial carcinoma (EC) is the most common malignancy of the female genital tract. Gene alterations and overexpression of various oncogenes are important in tumor development.
Kandemir Nilufer   +6 more
doaj   +1 more source

Skor Histologi C-Erbb-2, Proliferasi Endotel Pembuluh Darah: Pada Infiltrasi Levobupivakain Terhadap Penyembuhan Luka

open access: yesJAI (Jurnal Anestesiologi Indonesia), 2009
Latar Belakang: Nyeri akut paska bedah memicu timbulnya gejala klinis patofisiologis, menekan respon imun, sehingga menyebabkan penurunan sistem imun yang akan menghambat penyembuhan luka. Levobupivakain, anestetik lokal durasi panjang efektif mengurangi
Curniawati Trisasi, Marwoto Marwoto
doaj   +1 more source

Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer [PDF]

open access: yes, 2018
Background Endocrine therapies are the mainstay of treatment for oestrogen receptor (ER)-positive (ER+) breast cancer (BC). However, resistance remains problematic largely due to enhanced cross-talk between ER and growth factor pathways, circumventing ...
A Carracedo   +43 more
core   +6 more sources

Sclerostin–erbB-3 interactions: Modulation of erbB-3 activity by sclerostin [PDF]

open access: yesBiochemical and Biophysical Research Communications, 2010
To gain insights into the mechanism of action of sclerostin, a protein that regulates bone mass, we performed yeast two-hybrid analyses using human SOST (sclerostin) cDNA cloned into pGBKT7 DNA-binding domain vector as a bait, and a normalized, high-complexity, universal cDNA library in a GAL4 activating domain vector.
Theodore A, Craig, Rajiv, Kumar
openaire   +2 more sources

Home - About - Disclaimer - Privacy